share_log

奥翔药业董事会审计委员会对会计师事务所2023年度履行监督职责情况报告

Report on the audit committee of the board of directors of Aoxiang Pharmaceutical on the performance of supervisory duties by accounting firms in 2023

Sensex a share ·  Apr 26
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more